ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Symbol: NASDAQ:CFMS
- CUSIP: N/A
- Web: www.conformis.com
Capitalization:- Market Cap: $194.7 million
- Outstanding Shares: 43,850,000
Average Prices:- 50 Day Moving Avg: $4.22
- 200 Day Moving Avg: $5.65
- 52 Week Range: $3.79 - $10.93
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.78
- P/E Growth: 0.25
Sales & Book Value:- Annual Revenue: $80.1 million
- Price / Sales: 2.50
- Book Value: $1.82 per share
- Price / Book: 2.51
Profitability:- EBIDTA: ($55,080,000.00)
- Net Margins: -74.55%
- Return on Equity: -60.57%
- Return on Assets: -50.04%
Debt:- Debt-to-Equity Ratio: 0.18%
- Current Ratio: 6.13%
- Quick Ratio: 5.37%
Misc:- Average Volume: 281,854 shs.
- Beta: 2.15
- Short Ratio: 11.91
Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)
What is ConforMIS's stock symbol?
ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."
How were ConforMIS's earnings last quarter?
ConforMIS, Inc. (NASDAQ:CFMS) announced its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.04. The business earned $20.50 million during the quarter, compared to the consensus estimate of $18.48 million. ConforMIS had a negative net margin of 74.55% and a negative return on equity of 60.57%. ConforMIS's revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.37) EPS. View ConforMIS's Earnings History.
Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?
6 equities research analysts have issued 1 year target prices for ConforMIS's shares. Their predictions range from $7.50 to $14.00. On average, they anticipate ConforMIS's share price to reach $9.90 in the next twelve months. View Analyst Ratings for ConforMIS.
Who are some of ConforMIS's key competitors?
Who are ConforMIS's key executives?
ConforMIS's management team includes the folowing people:
- Kenneth Fallon III, Independent Chairman of the Board
- Mark A. Augusti, President, Chief Executive Officer, Director
- Paul S. Weiner, Chief Financial Officer
- Daniel Steines M.D., Chief Technology Officer
- David Cerveny, Chief Legal Officer and General Counsel
- Philipp Lang M.D., Director
- Bradley R. Langdale, Independent Director
- Colm C. Lanigan, Independent Director
- Richard J. Meelia, Independent Director
- Michael D. Milligan, Independent Director
When did ConforMIS IPO?
(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
Who owns ConforMIS stock?
ConforMIS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Creative Planning (0.06%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.
Who sold ConforMIS stock? Who is selling ConforMIS stock?
ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Creative Planning. Company insiders that have sold ConforMIS stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.
How do I buy ConforMIS stock?
Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ConforMIS's stock price today?
One share of ConforMIS stock can currently be purchased for approximately $4.57.
MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for ConforMIS (NASDAQ:CFMS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $9.90 (116.63% upside) |
Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/16/2017 | BTIG Research | Reiterated Rating | Hold | | Low |  |
| 6/20/2017 | Oppenheimer Holdings, Inc. | Reiterated Rating | Buy | | Low | |
| 5/16/2017 | B. Riley | Reiterated Rating | Buy | $7.50 | Low | |
| 5/11/2017 | Canaccord Genuity | Set Price Target | Hold | $8.00 | Low | |
| 11/4/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $11.00 | N/A | |
| 9/19/2016 | SunTrust Banks, Inc. | Initiated Coverage | Buy | $14.00 | N/A | |
| 5/13/2016 | Deutsche Bank AG | Lower Price Target | Buy | $26.00 -> $12.00 | N/A | |
| 5/13/2016 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | N/A | |
| 12/1/2015 | Sterne Agee CRT | Initiated Coverage | Buy | $26.00 | N/A | |
(Data available from 7/20/2015 forward)
Earnings History for ConforMIS (NASDAQ:CFMS)Earnings History by Quarter for ConforMIS (NASDAQ CFMS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/10/2017 | Q1 2017 | ($0.36) | ($0.40) | $18.48 million | $20.50 million | View | N/A | |
| 2/15/2017 | Q416 | ($0.30) | ($0.37) | $21.37 million | $21.70 million | View | Listen | |
| 11/3/2016 | Q316 | ($0.36) | ($0.31) | $18.27 million | $18.60 million | View | Listen | |
| 8/8/2016 | Q216 | ($0.35) | ($0.34) | $18.02 million | $19.30 million | View | Listen | |
| 5/12/2016 | Q116 | ($0.38) | ($0.37) | $19.23 million | $20.30 million | View | Listen | |
| 2/11/2016 | Q415 | ($0.41) | ($0.37) | $17.23 million | $19.10 million | View | Listen | |
| 11/2/2015 | Q3 | ($0.38) | ($0.45) | $13.51 million | $13.90 million | View | N/A | |
| 8/11/2015 | Q215 | ($1.31) | ($2.51) | $11.20 million | $19.20 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for ConforMIS (NASDAQ:CFMS)2017 EPS Consensus Estimate: ($1.44)
2018 EPS Consensus Estimate: ($1.36)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | ($0.38) | ($0.36) | ($0.37) |
| Q2 2017 | 3 | ($0.39) | ($0.35) | ($0.37) |
| Q3 2017 | 3 | ($0.37) | ($0.33) | ($0.35) |
| Q4 2017 | 3 | ($0.36) | ($0.34) | ($0.35) |
| Q1 2018 | 1 | ($0.34) | ($0.34) | ($0.34) |
| Q2 2018 | 1 | ($0.34) | ($0.34) | ($0.34) |
| Q3 2018 | 1 | ($0.34) | ($0.34) | ($0.34) |
| Q4 2018 | 1 | ($0.34) | ($0.34) | ($0.34) |
(Data provided by Zacks Investment Research)
Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ:CFMS)Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 39.31%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/20/2017 | Bradley Langdale | Director | Sell | 6,722 | $4.30 | $28,904.60 | |
| 4/26/2017 | Daniel Steines | Insider | Sell | 5,000 | $5.54 | $27,700.00 | |
| 4/5/2017 | Daniel Steines | Insider | Sell | 5,000 | $5.00 | $25,000.00 | |
| 2/15/2017 | Philipp Lang | Director | Sell | 137,968 | $8.60 | $1,186,524.80 | |
| 2/3/2017 | David Cerveny | Insider | Sell | 3,569 | $8.59 | $30,657.71 | |
| 2/3/2017 | Paul S Weiner | CFO | Sell | 2,676 | $8.42 | $22,531.92 | |
| 2/3/2017 | Philipp Lang | Director | Sell | 108,705 | $8.60 | $934,863.00 | |
| 1/25/2017 | Philipp Lang | Director | Sell | 108,985 | $8.60 | $937,271.00 | |
| 1/23/2017 | Philipp Lang | Director | Sell | 9,681 | $8.60 | $83,256.60 | |
| 1/13/2017 | Philipp Lang | Director | Sell | 37,275 | $8.60 | $320,565.00 | |
| 1/11/2017 | Philipp Lang | Director | Sell | 2,800 | $8.62 | $24,136.00 | |
| 1/10/2017 | Philipp Lang | Director | Sell | 83,909 | $8.64 | $724,973.76 | |
| 1/9/2017 | Philipp Lang | Director | Sell | 6,200 | $8.65 | $53,630.00 | |
| 1/5/2017 | Philipp Lang | Director | Sell | 400 | $8.60 | $3,440.00 | |
| 1/3/2017 | Philipp Lang | Director | Sell | 74,876 | $8.00 | $599,008.00 | |
| 12/30/2016 | Philipp Lang | Director | Sell | 168,734 | $8.25 | $1,392,055.50 | |
| 12/28/2016 | Philipp Lang | Director | Sell | 58,547 | $8.26 | $483,598.22 | |
| 12/27/2016 | Philipp Lang | Director | Sell | 42,086 | $8.57 | $360,677.02 | |
| 12/23/2016 | Philipp Lang | Director | Sell | 30,647 | $8.62 | $264,177.14 | |
| 10/17/2016 | Daniel Steines | Insider | Sell | 889 | $8.64 | $7,680.96 | |
| 10/17/2016 | Paul S Weiner | CFO | Sell | 884 | $8.60 | $7,602.40 | |
| 10/12/2016 | Daniel Steines | Insider | Sell | 10,000 | $9.66 | $96,600.00 | |
| 10/5/2016 | Philipp Lang | CEO | Sell | 53,860 | $10.19 | $548,833.40 | |
| 10/4/2016 | Philipp Lang | CEO | Sell | 400 | $10.00 | $4,000.00 | |
| 10/3/2016 | Daniel Steines | CTO | Sell | 10,000 | $10.03 | $100,300.00 | |
| 10/3/2016 | Philipp Lang | CEO | Sell | 10,410 | $10.03 | $104,412.30 | |
| 9/16/2016 | Daniel Steines | Insider | Sell | 30,000 | $9.09 | $272,700.00 | |
| 8/17/2016 | Kenneth P Fallon III | Director | Sell | 4,000 | $8.44 | $33,760.00 | |
| 5/17/2016 | Robert Law III | SVP | Buy | 1,600 | $6.20 | $9,920.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for ConforMIS (NASDAQ:CFMS)
Latest Headlines for ConforMIS (NASDAQ:CFMS)
| Source: |
|
| Date | Headline |
|---|
 | ConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - GlobeNewswire (press release)
globenewswire.com - July 20 at 4:21 AM |
 | ConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017
finance.yahoo.com - July 19 at 6:17 PM |
 | Comparing Uroplasty (UPI) & ConforMIS (NASDAQ:CFMS)
www.americanbankingnews.com - July 19 at 9:34 AM |
| St Jude Medical (STJ) versus ConforMIS (CFMS) Head-To-Head Survey
www.americanbankingnews.com - July 19 at 8:51 AM |
| BTIG Research Reiterates "Hold" Rating for ConforMIS, Inc. (CFMS)
www.americanbankingnews.com - July 18 at 12:56 AM |
| Financial Comparison: ConforMIS (CFMS) and St Jude Medical (STJ)
www.americanbankingnews.com - July 17 at 2:31 PM |
| $19.40 Million in Sales Expected for ConforMIS, Inc. (NASDAQ:CFMS) This Quarter
www.americanbankingnews.com - July 14 at 4:24 PM |
| ConforMIS, Inc. (CFMS) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 7:10 PM |
| ConforMIS Names Dan Krupp Senior Vice President US Sales - GlobeNewswire (press release)
globenewswire.com - July 12 at 5:42 PM |
| Brokerages Expect ConforMIS, Inc. (NASDAQ:CFMS) Will Post Earnings of -$0.36 Per Share
www.americanbankingnews.com - July 12 at 8:30 AM |
| Zacks Investment Research Lowers ConforMIS, Inc. (CFMS) to Sell
www.americanbankingnews.com - July 11 at 10:52 PM |
| ETFs with exposure to ConforMIS, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 6:08 PM |
| ConforMIS Names Dan Krupp Senior Vice President U.S. Sales
finance.yahoo.com - July 11 at 6:08 PM |
| ConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 10:59 AM |
| ETFs with exposure to ConforMIS, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 4:56 PM |
| RTI Surgical (RTIX) vs. ConforMIS (CFMS) Head to Head Contrast
www.americanbankingnews.com - June 25 at 12:17 PM |
| ConforMIS, Inc. (CFMS) Director Sells $28,904.60 in Stock
www.americanbankingnews.com - June 22 at 8:16 PM |
| ConforMIS, Inc. (CFMS) Given "Buy" Rating at Oppenheimer Holdings, Inc.
www.americanbankingnews.com - June 21 at 11:22 PM |
 | ConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - StreetInsider.com
www.streetinsider.com - June 20 at 9:55 PM |
| ConforMIS, Inc. (CFMS) Research Coverage Started at BTIG Research
www.americanbankingnews.com - June 20 at 5:30 PM |
| ConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System
www.streetinsider.com - June 20 at 4:53 PM |
| ConforMIS Announces FDA 510(k) Clearance for iTotal Hip System
finance.yahoo.com - June 20 at 4:53 PM |
| $19.40 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter
www.americanbankingnews.com - June 18 at 10:00 AM |
| ConforMIS (CFMS) versus HeartWare International (HTWR) Financial Analysis
www.americanbankingnews.com - June 16 at 10:48 PM |
| ETFs with exposure to ConforMIS, Inc. : June 16, 2017
finance.yahoo.com - June 16 at 5:00 PM |
| Analysts Anticipate ConforMIS, Inc. (CFMS) to Post -$0.36 EPS
www.americanbankingnews.com - June 16 at 8:46 AM |
| ConforMIS, Inc. :CFMS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 4:59 PM |
| Financial Comparison: Glaukos Corporation (GKOS) and ConforMIS (CFMS)
www.americanbankingnews.com - June 13 at 10:35 PM |
| ConforMIS Inc (CFMS) Announces Publication of Study Comparing Customized Knee Replacement Implants to Off-the ... - StreetInsider.com
www.streetinsider.com - June 13 at 3:48 PM |
| ConforMIS Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement Implants
finance.yahoo.com - June 13 at 12:44 PM |
| ConforMIS Inc (CFMS) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 6 at 8:42 AM |
| Analyzing RTI Surgical (RTIX) & ConforMIS (CFMS)
www.americanbankingnews.com - June 6 at 12:06 AM |
| ConforMIS Inc (CFMS) Expected to Announce Earnings of -$0.36 Per Share
www.americanbankingnews.com - May 19 at 1:20 PM |
| ConforMIS Inc (CFMS) Given "Buy" Rating at B. Riley
www.americanbankingnews.com - May 16 at 6:58 PM |
| ConforMIS Inc (CFMS) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 15 at 10:16 PM |
| Analysts Issue Forecasts for ConforMIS Inc's Q2 2017 Earnings (CFMS)
www.americanbankingnews.com - May 15 at 7:58 AM |
| Oppenheimer Holdings Comments on ConforMIS Inc's Q2 2017 Earnings (CFMS)
www.americanbankingnews.com - May 15 at 7:58 AM |
| ConforMIS's (CFMS) "Buy" Rating Reaffirmed at B. Riley
www.americanbankingnews.com - May 14 at 9:36 AM |
| ConforMIS Inc (CFMS) Given a $8.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - May 13 at 6:58 PM |
| ConforMIS Inc (CFMS) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 12 at 8:48 AM |
| Edited Transcript of CFMS earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - May 11 at 9:54 PM |
| ConforMIS Inc (CFMS) Given a $9.00 Price Target at Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 11 at 2:56 PM |
| ConforMIS Inc (CFMS) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - May 11 at 12:44 AM |
| ConforMIS reports 1Q loss
finance.yahoo.com - May 10 at 9:26 PM |
| Investor Network: ConforMIS Inc to Host Earnings Call
finance.yahoo.com - May 10 at 4:26 PM |
| ConforMIS Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 10 at 4:26 PM |
| ConforMIS (CFMS) Getting Somewhat Favorable Press Coverage, Analysis Finds
www.americanbankingnews.com - May 4 at 9:17 AM |
| ConforMIS (CFMS) Earning Somewhat Negative News Coverage, AlphaOne Reports
www.americanbankingnews.com - May 1 at 4:26 PM |
| ConforMIS Inc (CFMS) Expected to Announce Quarterly Sales of $18.4 Million
www.americanbankingnews.com - April 30 at 9:16 AM |
| ConforMIS Inc (CFMS) Insider Daniel Steines Sells 5,000 Shares
www.americanbankingnews.com - April 29 at 1:23 AM |
ConforMIS (CFMS) Chart for Thursday, July, 20, 2017
